September 16, 2013

DSN visited with Mike Greene, VP government relations for the Council for Responsible Nutrition, to talk about the role one of the leading VMS associations plays on Capitol Hill. "[Right now], the new dietary ingredients issue is one of the core issues that needs to be addressed," Greene said. "When I'm on Capitol Hill and talking about NDIs, I typically talk about it as the last piece of the puzzle that is the Dietary Supplement Health and Education Act."

September 11, 2013

Drug Store News sat down with Duffy MacKay, VP scientific and regulatory affairs for the Council for Responsible Nutrition, recently to discuss the science behind the supplements. "One of the big challenges in nutrition research, is the fact that the standard is a drug research model," MacKay noted. "There are several realities within nutrition science that don't lend themselves to be studied in the classic drug model."

September 9, 2013

The Drug Store News Group recently spoke with Judy Blatman, SVP communications for the Council for Responsible Nutrition, to discuss the communication and advocacy roles CRN conducts on behalf of the industry. "It's important that whatever we do defines a responsible industry," Blatman said. "And so we work on initiatives that put us front and center with the media, [making] us a respected voice in the scientific community, on Capitol Hill and in the international arena."

September 15, 2014

The external analgesic ingredient arnica and baby care are two categories that are moving the needle across the homeopathic landscape. 

September 15, 2014

According to a survey released earlier this year by the American Podiatric Medical Association, foot health ranks near the bottom on the list of body parts/functions that Americans make a concentrated effort to “take care of.”

August 21, 2014

There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.

August 20, 2014

Wahl is differentiating itself from other products on the shelf through a new approach that combines a massager with hot-cold gel packs, helping to increase circulation and reduce swelling.

August 20, 2014

Thanks in part to the launch of Alka-Seltzer Fruit Chews in May of last year, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

August 20, 2014

The lion’s share of the analgesics business may be in internal analgesics — sales of which totaled $3.6 billion, up 1.1% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI — but it’s alternative pain relievers that may represent the growth opportunity.

August 20, 2014

Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

With the recent switch of Chattem’s Nasacort 24HR, the first nasal corticosteroid to be sold OTC, Chattem launched a very unique marketing tool — an interactive shelf display that gives a whole new meaning to the term “shelf talker.”

August 20, 2014

Consumers buying hand sanitizer are shopping the set multiple times because of different needs, noted Tim Cleary, VP sales at Purell Consumer, suggesting there may be a latent opportunity for the already-growing Purell Advanced formula, which generated $20.6 million in sales, up 25.2%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

The successful introduction of Estroven Weight Management is bringing new users to the menopause supplement category, said April Mills, marketing director of i-Health, a division of DSM.

August 20, 2014

Excedrin relaunched in the United States in 2013 and is doing well. The brand generated $130 million between its Excedrin tablets and Excedrin Migraine tablets for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

Who is the alternative analgesic pain consumer? “The majority of these people [in search of external pain relief] have chronic pain and are already taking prescriptions and using multiple methods of pain relief,” said Jenny McLaughlin, product manager for Walh Therapeutic Massagers. “Our research shows people are coming into the health-and-wellness area once a month.”

August 20, 2014

Adult incontinence and urinary bladder control represent one of the more lucrative categories in OTC, but it’s not necessarily the most talked-about category.

August 20, 2014

The allergy remedy business is growing, and not just because of new entries to the market like Chattem’s Nasacort 24HR, which to date has brought in more than $50 million to the category. Allergy seasons are lasting longer, and there are more people suffering from allergies.

August 20, 2014

Reckitt Benckiser recently extended its Mucinex brand into the allergy set with the appropriately named Mucinex Allergy.

August 20, 2014

Reckitt Benckiser this season extended its line of popular Mucinex Fast-Max products, which provide multi-symptom relief, to include a product for nighttime cold-and-flu relief in both liquid and tablet form, taking on Procter & Gamble’s NyQuil franchise.

August 20, 2014

Perfecta Products last year added Zim’s Arnica Max to it’s lineup of external analgesic rubs, which includes Zim’s Max-Freeze, an $11.8 million brand grew 27.3% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

While nobody thought 2013-14 cough-cold sales would reach as high in comparison to the year before, no one expected the season to come down as much as it did.

August 20, 2014

The entire external analgesic category is up 6.7%, reaching a base of $486.9 million across total U.S. multi-outlets for the 52 weeks ended June 15, according to IRI data. And Salonpas, with a 10.9% dollar share, is helping to drive that growth with positive sales gains of 28.7% to $52.9 million.

August 20, 2014

Sales of sleep aids is still on the rise, driven primarily by private-label across both tablets and liquid formats.

August 20, 2014

Merck Consumer Care’s Oxytrol for Women brings women with overactive bladder concerns to the self-care aisle for the first time.